ArticleMedical mycology case reports2026
Pulmonary mucormycosis with endobronchial involvement due to
Article in Medical mycology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucormycosis is an opportunistic infection caused by fungi of the order Mucorales, primarily affecting immunocompromised individuals or those with disruption of skin or mucosal integrity. The most common clinical forms include pulmonary, rhino-orbito-cerebral, and cutaneous presentations. We report the case of a patient in his seventh decade of life with a history of diabetes mellitus who presented with a two-month history of paroxysmal cough with mucopurulent sputum, fever, and weight loss. Bronchoscopy and biopsy confirmed the diagnosis of endobronchial mucormycosis, an uncommon clinical presentation, with histopathological findings of sparsely septate, hyaline hyphae. The patient was started on amphotericin B therapy; however, his clinical course was unfavorable, developing multiorgan failure that led to death within 72 hours. Molecular sequencing of the specimen identified
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.